Published February 9, 2026 | Version v1

Comparative Analysis of early surfactant administration versus Standard Care in neonatal sepsis

  • 1. Krishna Research Center for Neonatology
  • 2. Ebro Research Center for Pediatric Research
  • 3. Amur Center for Pediatric Research

Description

Background: Neonatal sepsis frequently produces a secondary surfactant dysfunction syndrome that resembles primary respiratory distress syndrome, because inflammatory mediators and proteinaceous exudate inactivate pulmonary surfactant regardless of gestational maturity. Objective: This review synthesizes evidence comparing early exogenous surfactant administration with standard supportive care alone in neonates with sepsis-associated respiratory failure. Methods: We synthesized randomized trials, multicenter cohorts, and Cochrane reviews addressing surfactant timing, delivery technique, and respiratory outcomes in septic and infection-associated neonatal respiratory failure. Findings: Early surfactant reduces oxygenation index and need for extracorporeal support in term and near-term infants with sepsis-related respiratory failure, with the greatest benefit when given before severe decompensation; less invasive delivery extends this advantage to spontaneously breathing preterm infants, though surfactant inactivation by serum proteins blunts the response compared with primary respiratory distress syndrome. Conclusions: Early, protocol-driven surfactant administration alongside antimicrobial therapy and lung-protective ventilation offers measurable benefit over standard care alone in neonatal sepsis, but optimal timing and patient selection remain incompletely defined.

Notes

Copyright (C) 2026 Ramirez et al.

Files

Comparative Analysis of early surfactant administration versus Standard Care in neonatal sepsis.pdf